Practical Management of ANCA-Associated Vasculitis: A Clinician’s Perspective
Immunosuppression regimens have been refined due to emerging evidence from clinical trials. Rituximab, avacopan, and reduced-dose glucocorticoid schedules have been the focus of recent studies. Infections and immunosuppression-induced immunodeficiency must be considered when determining individualized treatment.
Authors
- Lucy Francis (ORCID: https://orcid.org/0000-0003-0946-2634)
- Hannah D. Stacey (ORCID: https://orcid.org/0000-0001-6218-0762)
- Rachel Bronwen Jones (ORCID: https://orcid.org/0000-0003-4790-283X)
- Rona Smith (ORCID: https://orcid.org/0000-0002-7438-5156)
Institutions
- University of Cambridge (GB)
- Addenbrooke's Hospital (GB)
Publication Details
- Journal
- Glomerular Diseases
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1159/000543159
- Citations
- 4
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 1.68
Funders
- NIHR Cambridge Biomedical Research Centre